{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-22-061412","form_type":"8-K","ticker":"ATXI","cik":"0001644963","company_name":"AVENUE THERAPEUTICS, INC.","filed_at":"2022-05-16T23:59:59+00:00","discovered_at":"2026-05-14T18:04:01.611540+00:00","generated_at":"2026-06-25T14:58:40.447365+00:00","sec_items":["1.01","3.01","5.02"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Avenue Therapeutics enters stock contribution for Baergic Bio; Nasdaq non-compliance for audit committee","bullets":["Entered stock contribution agreement with parent Fortress to acquire 100% of Baergic Bio; conditions include $7.5M equity financing and repurchase of InvaGen shares.","Director Jay Kranzler determined not independent under Nasdaq rules; resigned from audit committee on May 13, 2022.","Company notified Nasdaq of non-compliance with audit committee composition rule; cure period available under Nasdaq Rule 5605(c)(4).","Faith L. Charles appointed to Board and audit committee to fill vacancies, effective May 16, 2022."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-22-061412","json":"https://secwatch.observer/filing/0001104659-22-061412.json","markdown":"https://secwatch.observer/filing/0001104659-22-061412.md","text":"https://secwatch.observer/filing/0001104659-22-061412.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1644963/000110465922061412/0001104659-22-061412-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1644963/000110465922061412/tm2215290d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T14:58:40.447365+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"e5d6404320","claim":"Faith L. Charles was appointed as director at AVENUE THERAPEUTICS, INC..","evidence_excerpt":"On May 16, 2022, the Board appointed Faith L. Charles as a director","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1644963/000110465922061412/0001104659-22-061412-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}